Vitamin D receptor gene polymorphisms and the risk for female reproductive cancers: A meta-analysis - PubMed (original) (raw)
Meta-Analysis
Vitamin D receptor gene polymorphisms and the risk for female reproductive cancers: A meta-analysis
Myung-Jin Mun et al. Maturitas. 2015 Jun.
Abstract
Vitamin D receptor (VDR) gene polymorphisms and the risks for various breast and ovarian cancers have been reported in many epidemiological studies. However, the associations between VDR gene polymorphisms and the risk for each type of cancer are unclear. The aim of this meta-analysis was to evaluate the associations between VDR gene polymorphisms and female reproductive cancers. A systematic review was performed with the PubMed Science Direct, Scopus, and Google Scholar databases up to April 2014 using the search terms "vitamin D receptor or VDR" and "variant or polymorphism or SNP" with terms for breast, ovarian, cervical, endometrial, uterine, and vaginal cancers. A meta-analysis with the pooled odds ratios and 95% confidence intervals was carried out to assess the associations between VDR polymorphisms (Cdx-2, FokI, BsmI, ApaI, and TaqI) and the risks for reproductive cancers under the heterozygous, homozygous, dominant, and recessive models with fixed or random effects models. Six ovarian cancer studies (13 individual studies involving 4107 cases and 6661 controls) and 29 breast cancer studies (38 individual studies involving 16,453 cases and 22,044 controls) were included in our meta-analysis. Our results indicate that the FokI polymorphism was related to increased risks for breast and ovarian cancers, whereas the BsmI polymorphism was associated with a decreased risk for developing these cancers. Our comprehensive meta-analysis indicated that the FokI and BsmI VDR gene polymorphisms may be significantly associated with gynecological cancers. We suggest monitoring VDR gene polymorphisms as potential biomarkers in patients with gynecological malignancy.
Keywords: Female; Meta-analysis as topic; Polymorphism; Vitamin D receptor.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Similar articles
- Polymorphisms in the vitamin D Receptor (VDR) and the risk of ovarian cancer: a meta-analysis.
Liu Y, Li C, Chen P, Li X, Li M, Guo H, Li J, Chu R, Wang H. Liu Y, et al. PLoS One. 2013 Jun 24;8(6):e66716. doi: 10.1371/journal.pone.0066716. Print 2013. PLoS One. 2013. PMID: 23826116 Free PMC article. - Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer: a meta-analysis.
Song GG, Lee YH. Song GG, et al. Immunol Invest. 2013;42(7):661-72. doi: 10.3109/08820139.2013.822881. Immunol Invest. 2013. PMID: 24004063 - Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder.
Coşkun S, Şimşek Ş, Camkurt MA, Çim A, Çelik SB. Coşkun S, et al. Gene. 2016 Aug 22;588(2):109-14. doi: 10.1016/j.gene.2016.05.004. Epub 2016 May 4. Gene. 2016. PMID: 27155524 - Association between VDR polymorphisms and rheumatoid arthritis disease: Systematic review and updated meta-analysis of case-control studies.
Tizaoui K, Hamzaoui K. Tizaoui K, et al. Immunobiology. 2015 Jun;220(6):807-16. doi: 10.1016/j.imbio.2014.12.013. Epub 2014 Dec 30. Immunobiology. 2015. PMID: 25577294 Review. - Do genetic polymorphisms of the vitamin D receptor contribute to breast/ovarian cancer? A systematic review and network meta-analysis.
Li J, Li B, Jiang Q, Zhang Y, Liu A, Wang H, Zhang J, Qin Q, Hong Z, Li BA. Li J, et al. Gene. 2018 Nov 30;677:211-227. doi: 10.1016/j.gene.2018.07.070. Epub 2018 Jul 29. Gene. 2018. PMID: 30059751 Review.
Cited by
- Vitamin D in Cancer Prevention and Treatment: A Review of Epidemiological, Preclinical, and Cellular Studies.
Dallavalasa S, Tulimilli SV, Bettada VG, Karnik M, Uthaiah CA, Anantharaju PG, Nataraj SM, Ramashetty R, Sukocheva OA, Tse E, Salimath PV, Madhunapantula SV. Dallavalasa S, et al. Cancers (Basel). 2024 Sep 20;16(18):3211. doi: 10.3390/cancers16183211. Cancers (Basel). 2024. PMID: 39335182 Free PMC article. Review. - Vitamin D and vitamin D receptor polymorphism in Asian adolescents with primary dysmenorrhea.
Donayeva A, Amanzholkyzy A, Nurgaliyeva R, Gubasheva G, Saparbayev S, Ayaganov D, Kaldybayeva A, Abdelazim IA, Farghali MM. Donayeva A, et al. BMC Womens Health. 2023 Aug 5;23(1):414. doi: 10.1186/s12905-023-02569-9. BMC Womens Health. 2023. PMID: 37543584 Free PMC article. - Vitamin D, Menopausal Health and COVID-19: Critical Appraisal of Current Data.
Anagnostis P, Livadas S, Goulis DG, Rees M, Lambrinoudaki I. Anagnostis P, et al. J Clin Med. 2023 Jan 24;12(3):916. doi: 10.3390/jcm12030916. J Clin Med. 2023. PMID: 36769563 Free PMC article. Review. - Immunohistochemical Expression of Vitamin D Receptor in Uterine Fibroids.
Markowska A, Kurzawa P, Bednarek W, Gryboś A, Mardas M, Krzyżaniak M, Majewski J, Markowska J, Gryboś M, Żurawski J. Markowska A, et al. Nutrients. 2022 Aug 17;14(16):3371. doi: 10.3390/nu14163371. Nutrients. 2022. PMID: 36014877 Free PMC article. - 1α,25(OH)2D3(VD3) promotes Raddeanin A-induced anti-proliferative effects on HeLa cell apoptosis and autophagy through negative regulation of HPV18E6-E7/PD-L1/VDR axis.
Li Z, Xu B, Sun Y, Zhou L, Tao Y, Hou W, Bao J, Liu J, Fan W. Li Z, et al. Bioengineered. 2022 Jan;13(1):357-369. doi: 10.1080/21655979.2021.2005223. Bioengineered. 2022. PMID: 34974811 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous